Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

January 31, 2016

Conditions
HypertensionDiabetes Mellitus, Type 2Hypercholesterolemia
Interventions
OTHER

Proteus Discover

FDA cleared Wearable Sensor with Ingestible Sensor and Mobile Device Application

OTHER

Usual Care

Routine medical care including medication titration, adherence counseling, and lifestyle coaching.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Proteus Digital Health, Inc.

INDUSTRY